The company has not filed an annual or quarterly report since its FY2016 10-K, filed Mar 1, 2017. Its latest SEC filing is a SC 13G/A from Feb 18, 2020.
10-K for FY2016, filed Mar 1, 2017
The sections below describe the company as of the FY2016 annual report.
Sells CoolSculpting systems and procedure packs for non-invasive fat reduction to physicians and aesthetic practices.
10-K for FY2016, filed Mar 1, 2017
In North America, the company sells directly to physicians and aesthetic practices; outside North America, it sells through both a direct sales force and distributors to similar customers.
10-K for FY2016, filed Mar 1, 2017
8-K, filed Apr 28, 2017
Under the Merger Agreement, each share of the Company’s common stock (the “Company Common Stock”) issued and outstanding immediately prior…View ↗
Expanded treatment areas
CoolSculpting's cleared treatment areas expanded beyond the flanks and abdomen named in the older report to include the thigh, under-chin, upper-arm and other areas in the newer report.
10-K for FY2013, filed Feb 26, 2014 10-K for FY2016, filed Mar 1, 2017ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing our proprietary…View ↗
ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing our proprietary…View ↗
Broader physician customer base
The latest report adds general practice physicians to the customer groups it names, alongside dermatologists, plastic surgeons and aesthetic specialists; the older report names the latter three.
10-K for FY2013, filed Feb 26, 2014 10-K for FY2016, filed Mar 1, 2017We market CoolSculpting to dermatologists, plastic surgeons, and aesthetic specialists. Aesthetic specialists are physicians who elect to…View ↗
We market CoolSculpting to dermatologists, plastic surgeons, aesthetic specialists and general practice physicians. Aesthetic specialists…View ↗
Loading...
